Early intervention for depressive disorders in young people : the opportunity and the ( lack of ) evidence

Young people experiencing their first onset of depression are a group at risk of relapse and recurrence to whom early intervention and prevention efforts should be targeted. Despite the argument for a significant research effort addressing these issues, the evidence regarding optimal intervention strategies for first episodes is lacking. Cognitive behaviour therapy is an effective approach to treatment and relapse prevention among depressed adolescents, and is likely to be an important component of any evidenced‐based approach to early intervention. Antidepressants are not recommended as first‐line treatment for most first episodes of depression. The role that they may play in patients with severe depression, or those who do not respond to psychological therapies, requires further evaluation. Given the high prevalence of depressive disorders, and the significant burden of disease they represent within our community, early intervention in depressive disorders is a critical research agenda for the future.

[1]  P. Lewinsohn,et al.  Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. , 1993, Journal of abnormal psychology.

[2]  E. Uhlenhuth,et al.  Long‐term effectiveness of cognitive therapy in major depressive disorder , 2004, Depression and anxiety.

[3]  R. Dahl,et al.  Childhood and adolescent depression: a review of the past 10 years. Part I. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  R. Weller,et al.  Treatment options in the management of adolescent depression. , 2000, Journal of affective disorders.

[5]  J. Racoosin,et al.  Suicide Rates in Short-term Randomized Controlled Trials of Newer Antidepressants , 2006, Journal of clinical psychopharmacology.

[6]  R. Harrington,et al.  Prevention and early intervention for depression in adolescence and early adult life , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[7]  Philip B. Ward,et al.  Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression , 2005, British Journal of Psychiatry.

[8]  Alex J Sutton,et al.  Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. , 2006, Archives of internal medicine.

[9]  Andrew C Leon,et al.  Expanding the black box - depression, antidepressants, and the risk of suicide. , 2007, The New England journal of medicine.

[10]  Paul J. Harrison,et al.  The neuropathology of primary mood disorder. , 2002, Brain : a journal of neurology.

[11]  R. Lam,et al.  Evidence-based strategies for achieving and sustaining full remission in depression: focus on metaanalyses. , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[12]  A. Rush,et al.  A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. , 1997, Archives of general psychiatry.

[13]  I. Gotlib,et al.  First onset versus recurrence of depression: differential processes of psychosocial risk. , 1999, Journal of abnormal psychology.

[14]  J. McCracken,et al.  Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[15]  S. Merry Prevention and early intervention for depression in young people – a practical possibility? , 2007, Current opinion in psychiatry.

[16]  R. Post,et al.  Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. , 1992, The American journal of psychiatry.

[17]  J. S. Simon,et al.  Extended-release venlafaxine in relapse prevention for patients with major depressive disorder. , 2004, Journal of psychiatric research.

[18]  Z. Segal,et al.  Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. , 2000, Journal of consulting and clinical psychology.

[19]  Eric Vermetten,et al.  Childhood trauma associated with smaller hippocampal volume in women with major depression. , 2002, The American journal of psychiatry.

[20]  K. Wagner,et al.  Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  M. Keller,et al.  Relapse Prevention With Gepirone ER in Outpatients With Major Depression , 2005 .

[22]  P. Lewinsohn,et al.  Are adolescents changed by an episode of major depression? , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[23]  P. Lewinsohn,et al.  Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. , 1998, Clinical psychology review.

[24]  R. Harrington,et al.  Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[25]  G. Simon Collaborative care for depression , 2006, BMJ : British Medical Journal.

[26]  J. Higgs The Depressed Child and Adolescent. , 1997 .

[27]  Phil A. Silva,et al.  Adult mental health and social outcomes of adolescent girls with depression and conduct disorder , 1996, Development and Psychopathology.

[28]  S. Andersen Trajectories of brain development: point of vulnerability or window of opportunity? , 2003, Neuroscience & Biobehavioral Reviews.

[29]  Hongjie Zheng,et al.  Escitalopram continuation treatment prevents relapse of depressive episodes. , 2004, The Journal of clinical psychiatry.

[30]  T. Vos,et al.  Cost-Effectiveness of Cognitive–Behavioural Therapy and Drug Interventions for Major Depression , 2005, The Australian and New Zealand journal of psychiatry.

[31]  G. Walter,et al.  Clinical guidance on the use of antidepressant medications in children and adolescents. , 2005, Australian family physician.

[32]  K. Kendler,et al.  Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. , 2000, The American journal of psychiatry.

[33]  J. Teasdale,et al.  Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. , 2004, Journal of consulting and clinical psychology.

[34]  R. Duman,et al.  Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.

[35]  Richard M Glass,et al.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. , 2005, The Journal of pediatrics.

[36]  A. Albano,et al.  Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[37]  D. Kupfer,et al.  Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review , 2003, The Lancet.

[38]  G. Feder,et al.  NICE guidelines for the management of depression , 2005, BMJ : British Medical Journal.

[39]  P. Lewinsohn,et al.  Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[40]  Jason L. Horowitz,et al.  The prevention of depressive symptoms in children and adolescents: A meta-analytic review. , 2006, Journal of consulting and clinical psychology.

[41]  J. Savarino,et al.  Suicide risk during antidepressant treatment. , 2006, The American journal of psychiatry.